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Abstract
Background: Children with complex urogenital anomalies often require bladder reconstruction. Gastrointestinal tissues
used in bladder augmentations exhibit a greatly increased risk of malignancy, and the bladder microenvironment may play
a role in this carcinogenesis. Investigating the influences of the bladder microenvironment on gastrointestinal and urothelial
cell cycle checkpoint activation and DNA damage response has been limited by the lack of an appropriate well-
differentiated urothelial cell line system.
Methodology/Principal Findings: To meet this need, we have developed a well-differentiated conditionally immortalized
urothelial cell line by isolating it from the H-2K
b-tsA58 transgenic mouse. These cells express a thermosensitive SV40 large T
antigen that can be deactivated by adjustment of cell culture conditions, allowing the cell line to regain normal control of
the cell cycle. The isolated urothelial cell line demonstrates a polygonal, dome-shaped morphology, expresses cytokeratin
18, and exhibits well-developed tight junctions. Adaptation of the urothelial cell line to hyperosmolal culture conditions
induces expression of both cytokeratin 20 and uroplakin II, markers of a superficial urothelial cell or ‘‘umbrella cell.’’ This cell
line can be maintained indefinitely in culture under permissive conditions but when cultured under non-permissive
conditions, large T antigen expression is reduced substantially, leading to increased p53 activity and reduced cellular
proliferation.
Conclusions/Significance: This new model of urothelial cells, along with gastrointestinal cell lines previously derived from
the H-2K
b-tsA58 transgenic mouse, will be useful for studying the potential mechanisms of carcinogenesis of the
augmented bladder.
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Introduction
Bladder cancer is one of the most common cancers of the
urinary tract, with approximately 330,000 new cases worldwide
per year [1], and an estimated age-adjusted incidence in the
United States of 21.1 per 100,000 men and women per year [2].
Bladder cancer is associated with environmental exposures such as
tobacco use [3], occupational carcinogens [4], and infection with
Schistosoma haematobium [5]. Because many environmental muta-
genic compounds are concentrated in the urine, bladder
epithelium is frequently exposed to genotoxic stress. The resultant
DNA damage must be repaired effectively in order to maintain
genomic stability and avoid malignant transformation.
The gastrointestinal tissue portion of bladder augmentations
exhibits an eight- to fifteen-fold increased risk of malignancy over
that of native bladder tissues [6]. The etiology of this increased risk
is poorly understood but may stem from cellular stresses
experienced by the non-native bladder tissue in the bladder
microenvironment [7]. Both acute exposure and gradual adapta-
tion to hyperosmolal conditions lead to the accumulation of DNA
damage and cause this accumulation by disruption of components
of the DNA damage response pathway [8,9]. Urothelial cells lining
the mammalian lower urinary tract have adapted to the
hyperosmolal urinary microenvironment by organizing into a
stratified epithelium, developing tight junctions [10,11] and
forming the asymmetric unit membrane (AUM) consisting of
uroplakins [12]. Urothelial cells also accumulate osmolytes such as
betaine, myo-inositol, and taurine [13] to balance the effects of
hyperosmolality. Using transitional cell carcinoma cell lines, we
recently identified that bladder-derived cells maintain the capacity
to recognize and repair DNA damage within hyperosmolal
microenvironments [14]. Activation of the DNA damage response
following adaptation to a hyperosmolal microenvironment appears
to be tissue-specific to bladder-derived cells, as we found that these
processes are compromised in gastric- and colon-derived adeno-
carcinoma cell lines [14] under such hyperosmolal conditions. A
tissue-specific capacity of urothelial cells to activate the DNA
damage response under osmotic stress, and corresponding failure
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16595of gastrointestinal cells to do so, may underlie the accumulation of
mutations in the gastrointestinal tissues in augmentation cysto-
plasties [15], potentially leading to their increased risk of
carcinogenesis [6,7].
Unfortunately, the systematic examination of such tissue-specific
effects of the bladder microenvironment on DNA damage
recognition is hampered by the lack of truly appropriate urothelial
models. Cultured primary urothelial cells are highly differentiated
[10], but demonstrate phenotypic variability between passages
[16,17], and undergo senescence after a finite number of passages
[18,19]. Urothelial cells immortalized by the wild-type SV40 large
T antigen such as the UROtsa and BL-1 cell lines express some
markers of urothelium [20,21], and are phenotypically stable
between generations. However, because the large T antigen binds
critical proteins such as p53 (for review see Cheng et al [22]), its
constitutive expression may interfere with activation of cell cycle
checkpoints and apoptosis in response to DNA damage. Similarly,
the urothelial cell line derived by Chapman et al is constitutively
immortalized by human telomerase reverse transcriptase
(hTERT), and although demonstrated to be non-tumorigenic in
vivo [19], may not be suitable for assessing the cell biology of
malignant transformation as telomerase expression alters the
expression of genes regulating tumorigenesis [23]. Well-differen-
tiated transitional cell carcinoma cell lines such as RT4 and KK47
[24,25] also express markers of urothelial differentiation such as
uroplakins and cytokeratins [26,27], but have profound derange-
ments in cell cycle regulation limiting their usefulness as a model of
urothelium to study the DNA damage response.
To circumvent the limitations and complement the capacities of
current model systems, we developed a conditionally immortalized
urothelial cell line derived from H-2K
b-tsA58 mice. Use of these
animals to produce primary cell lines that are conditionally
immortalized has been well described in the scientific literature
[28–34]. The derived cell line exhibited differentiation characteristics
of urothelium including a polygonal, dome-shaped monolayer of cells
with well-developed tight junctions and cytokeratin 18 expression.
Cytokeratin 20 and uroplakin II expression could be induced by
adaptation of the cells to hyperosmolal culture conditions. In
addition, cell cycle control was restored by significant reduction of
the SV40 large T antigen and an increase in the cellular activity of
p53 under non-permissive conditions as evidenced in part by a
decrease in cell proliferation. Likewise the activation of cell cycle
checkpoints in response to DNA damage was intact under these latter
conditions as was evidenced by S-phase cell cycle arrest following the
induction of double strand breaks. To our knowledge, this is the first
urothelial cell line that is both well-differentiated and conditionally
immortalized, exhibiting normal regulation of cell proliferation and
cell cycle checkpoint activation by adjustment of culture conditions.
As such, this cell line is an invaluable model of urothelium for studies
focused on bladder carcinogenesis, and is the appropriate cell line for
comparison to similarly-derived gastrointestinal epithelial cell lines to
elucidate the mechanisms underlyingtheincreased riskof malignancy
of augmented bladders.
Methods
Ethics Statement
The Institutional Animal Care and Use Committee and
Institutional Biosafety Committee of the Cincinnati Children’s
Research Foundation approved all animal experimental proce-
dures (IACUC protocol #9D09068 and IBC Protocol #2009-
0086), and these experiments were carried out in accordance with
standards as described in the NIH Guide to the Care and Use of
Laboratory Animals.
Preparation of Explant Cultures of Urothelium from
Mouse Bladder
The H-2K
b-tsA58 mouse (Immortomouse
TM), transgenic for the
thermosensitive mutant of the SV40 large T antigen (tsA58)
expressed by an interferon-inducible MHC Class I promoter, was
obtained from Charles River Laboratories, (Wilmington, MA).
The tsA58 antigen is ubiquitously expressed, although at the non-
permissive body temperature of the mouse (39uC) the protein
product of the transgene is unstable and is degraded. Once tissues
are removed from the animal, cell lines established from these
tissues may be conditionally immortalized under permissive tissue
culture conditions of 33uC and in the presence of recombinant
mouse interferon gamma (IFN-c).
ULTI (Urothelial Large T, Inducible) cells were isolated from
these mice using a modification of procedures described by Kreft
et al [16,17]. Briefly, following CO2 asphyxiation, an incision was
made from the symphysis pubis through the sternum, and the
urinary bladder was resected in its entirety. Bladders were rinsed
with phosphate-buffered saline (PBS), divided sagitally into two
equal parts, and mucosa separated from the muscle layer and
submucosa. The mucosa was applied to Cyclopore 0.45 mm
membrane supports (Becton Dickinson, Franklin Lakes, NJ) in 6
well dishes. Each well contained DMEM:Ham’s F12 media
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine
serum (FBS, Hyclone, Logan, UT), 1% penicillin/streptomycin
(Invitrogen), amphotericin B 2.5 mg/ml (Sigma, St. Louis, MO),
1% insulin/transferrin/ethanolamine/selenium (ITES) media
supplement (Sigma), mouse epidermal growth factor 10 ng/ml
(Sigma), and mouse IFN-c 10 U/ml (Invitrogen). Cultures were
incubated at 5% CO2,3 7 uC for 24 hours, then incubated at 5%
CO2,3 3 uC and observed for growth. Media was refreshed from
both the inserts and wells twice weekly. Once outgrowth of cells
from the mucosal pieces became confluent (at approximately 28
days in culture), the cells were subcultured with 0.25% trypsin and
0.02% EDTA onto 100 mm plastic dishes coated with type I
collagen (Becton Dickinson). To drive the ULTI urothelial cells
towards a non-transformed phenotype, subcultured cells were
grown at 37uC in media identical to that used in the explant
Table 1. Reverse transcriptase PCR primer pairs, annealing
temperature (Tannealing), and predicted PCR product size for
cytokeratin 18, cytokeratin 20, uroplakin II, and
glyceraldehyde-3-phosphate dehydrogenase (G3PDH).
Primer Pairs TAnnealing
Predicted
Product Size
Mus musculus Cytokeratin 18 (Krt18)5 8 uC 469 bp
Forward TTTAGAGTCAAGTATGAGAC
Reverse AGTTGATGTTCTGGTTTTTC
Mus musculus Cytokeratin 20 (Krt20)5 2 uC 467 bp
Forward TCAGATTGAAGTTTGAGACT
Reverse CAGAGACTCTTTCATGCTGA
Mus musculus Uroplakin II (Upk2)6 5 uC 233 bp
Forward CGACAGCAAAGTGGTTAAGT
Reverse CCATGTTTTTTCGAGGAAGC
Mus musculus G3PDH (Gapdh)5 8 uC 752 bp
Forward AGGTCGGTGTGAACGGATT
Reverse ATACTTGGCAGGTTTCTCCA
doi:10.1371/journal.pone.0016595.t001
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amphotericin B and the reduction of the FBS concentration to
0.5%.
Established Cell Lines and Reagents
The RT4 transitional cell carcinoma and NIH 3T3 mouse
fibroblast cell lines were obtained from the American Type
Culture Collection (ATCC, Manassas, VA) and maintained in cell
culture in DMEM:F12 media (Invitrogen) supplemented with 10%
FBS and 1% penicillin/streptomycin. Conditionally immortalized
gastrointestinal epithelial cell lines ImSt (gastric), YAMC (colon),
and MSIE (small intestine), also derived from the H-2K
b-tsA58
mouse, were generous gifts from Dr. Robert Whitehead
(Vanderbilt University, Nashville, TN) and were maintained in
identical media to our derived urothelial cell line. Etoposide,
pifithrin-a and sterile filtered DMSO were obtained from Sigma
Chemical.
Crystal violet cell proliferation assay
ULTI cells were seeded into 96 well plates at a density of 5000
cells/well in complete media containing FBS at concentrations of
10%, 5%, 3%, 2%, 1%, 0.75%, 0.5%, 0.25%, and 0%, both with
and without IFN-c. Cultures containing IFN-c were incubated at
33uC, and cultures lacking IFN-c were incubated at 37uC, both for
72 hours. Wells were then washed with PBS, fixed with 4%
paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA),
washed with ddH2O, and incubated with 0.1% crystal violet
(Becton Dickinson) for 30 minutes. Cells were again washed with
ddH2O, and treated with 10% glacial acetic acid. Absorbance was
then read at 540 nm with a Bio-Rad Benchmark Plus microplate
spectrophotometer. The experiment was carried out in triplicate,
and to account for minor variation in initial seeding density
between experiments, absorbances from each experiment were
normalized to that of 10% FBS in both conditions. Student’s t-test
was applied between absorbances measured from cells cultured at
33uC and from cells cultured at 37uC for each concentration of
FBS to determine statistical significance.
Cell cycle analysis by flow cytometry
ULTI cells were seeded into 60 mm plastic dishes at a density of
1610
5 cells/dish in complete media containing either 10% or
0.5% FBS, both with and without the addition of 10 U/ml IFN-c.
Cultures containing IFN-c (with either 10% or 0.5% FBS) were
incubated at 33uC, and cultures lacking IFN-c (with either 10% or
0.5% FBS) were incubated at 37uC, each for 72 hours. Cells were
then detached with trypsin-EDTA (Invitrogen), pelleted by
centrifugation, resuspended in staining buffer consisting of
propidium iodide 50 mg/mL, NP-40 0.3%, and RNAse A 1 mg/
mL in PBS, and incubated at 4uC for 30 minutes. Cells were then
filtered, analyzed with a Becton-Dickinson FACSCanto II
cytometer, and the resulting data was interpreted using FlowJo
v8.8.6 (TreeStar, Ashland, OR). Experiments were carried out in
triplicate, and the mean percentage of cells in G0/G1, S, and G2/
M phases were calculated.
In a separate set of experiments, cells were seeded at a density of
1610
5 cells/dish in complete media containing either 10% FBS
and 10 U/ml IFN-c, or 0.5% FBS without IFN-c. Cultures
containing IFN-c and 10% FBS were incubated at 33uC, and
cultures without IFN-c and 0.5% FBS were incubated at 37uC,
each for 72 hours. At 60 hours of incubation, cells were treated
with etoposide (a potent inhibitor of topoisomerase II that causes
double strand DNA breaks) at a final concentration of 25 mM, or a
similar volume of the DMSO vehicle. Cells were then detached,
pelleted, stained with propidium iodide, and analyzed in the same
manner as the previous experiment.
In a third set of experiments, cells were seeded at a density of
1610
5 cells/dish in complete media without IFN-c containing
0.5% FBS and incubated at 37uC for 72 hours. At 54 hours of
incubation, cells were treated with either pifithrin-a (a specific
inhibitor of p53) at a final concentration of 20 mM or a similar
volume of the DMSO vehicle, then at 60 hours of incubation
(without washing) treated with etoposide 25 mM or DMSO
vehicle. Cells were then detached, pelleted, stained with propidium
iodide, and analyzed in the same manner as the previous
experiments.
Western blot analysis
ULTI cells were subcultured onto plastic dishes both in
complete media containing 10% FBS as described above, as well
as in media lacking IFN-c and containing 0.5% FBS, at a density
of 1.0610
6 cells per 100 mm dish. NIH 3T3 fibroblasts were also
cultured in standard media as described above. ULTI cultures
were either maintained at 33uC in the presence of IFN-c,o r3 7 uC
in the absence of IFN-c for twenty-four hours, treated with either
pifithrin-a 20 mM or DMSO vehicle for six hours, then (without
washing) treated with either etoposide 25 mM or DMSO vehicle
for twelve hours. Whole cell lysates were then generated by lysis
into ice-cold RIPA buffer (50 mM Tris HCl pH 8, 150 mM NaCl,
1% Nonidet-P40, 0.5% sodium deoxycholate, 0.1% SDS)
supplemented with protease and phosphatase inhibitors (10 mM
NaF, 1 mM Na3VO4, 1 mM PMSF, 2 mg/ml aprotinin, and
10 mg/ml leupeptin). Cell suspensions were sonicated and cellular
debris was pelleted by centrifugation. Supernatants were aliquoted
and stored at -80uC.
Protein concentration of these lysates was determined by
bicinchoninic acid assay (Pierce, Rockford, IL) according to the
manufacturer’s instructions. Equal amounts of protein were
separated by SDS-PAGE and transferred to Immobilon-P PVDF
membranes (Millipore, Billerica, MA). Membranes were blocked
with 5% nonfat dry milk in TBS with 0.1% Tween 20 v/v (TBST),
then probed with antibody against SV40 large T antigen (1:2000,
Santa Cruz Biotechnology, Santa Cruz, CA); total p53 (1:40,000),
phospho-p53, serine 15 (1:10,000), cleaved caspase 3 (1:1000), and
PARP (1:2000) (Cell Signaling Technology, Danvers, MA); p21
cip1
(1:1000, BD Pharmingen, San Jose, CA), total ATM (1:1000,
Novus Biologicals, Littleton, CO), phospho-ATM, serine 1981
(1:1000, Rockland Immunologicals, Gilbertsville, PA), and
cH2AX (1:2000, Trevigen, Gaithersburg, MD). Equal protein
loading was confirmed by blotting for G3PDH (1:40,000;
Figure 1. The ULTI mouse urothelial cell line is conditionally immortalized under permissive conditions, but restores cell cycle
control under non-permissive conditions. A) Crystal violet proliferation assay, in which absorbances were normalized to that of 10% FBS to
reduce interexperimental variability. Open circles represent cells grown under permissive conditions (33uC +IFN-c), whereas closed circles represent
cells grown under non-permissive conditions (37uC -IFN-c). Error bars represent standard error of the mean. B) Cell cycle analysis of ULTI cells under
both permissive and non-permissive conditions, and with 10% and 0.5% FBS concentration, by propidium iodide DNA labeling flow cytometry. C)
Quantitation of cell cycle phase of ULTI cells under both permissive and non-permissive conditions, and with 10% and 0.5% FBS concentration. Dark
grey bars indicate percent of cells in G0/G1, white bars indicate percent of cells in S phase, and light grey bars indicate percent of cells in G2/M phase.
Error bars represent standard error of the mean.
doi:10.1371/journal.pone.0016595.g001
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peroxidase-linked secondary antibody (GE Healthcare Bioscienc-
es, Piscataway, NJ), and protein bands detected by chemilumi-
nescence with the Amersham ECL Plus kit (GE Healthcare
Biosciences) and developed by autoradiography.
Phase contrast and scanning electron microscopy of ULTI
cells
ULTI cells subcultured onto plastic dishes were examined with
Ko ¨hler illumination by phase contrast microscopy on a Zeiss
Axiovert 200M inverted microscope using the 20x objective. Cells
were also subcultured onto Cyclopore 0.45 mm membrane
supports (Becton Dickinson), then once the cells reached
confluence fixed with 2% (w/v) paraformaldehyde and 2% (v/v)
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, for 2 hours at
4uC. After rinsing in 0.1 M cacodylate buffer and postfixation with
1% (w/v) OsO4, specimens were chemically desiccated with
1,1,1,3,3,3-hexamethyldisilazane (Sigma). Subsequently, the cells
were sputter-coated with a gold/palladium 40% mixture in a
Denton Vacuum Desk IV, and examined in a Hitachi S-3000N
scanning electron microscope.
Immunofluorescence of cytokeratin 18, ZO-1, and
occludin
ULTI cells were seeded onto glass coverslips, and maintained at
37uC in the absence of IFN-c for four days. Cells were then rinsed
with ice-cold PBS, fixed with 4% paraformaldehyde in PBS, and
permeabilized with 0.5% Triton X-100 (Sigma) in PBS. Cells were
blocked with 15% FBS in PBS, then incubated either with mouse
monoclonal anti-cytokeratin 18 antibody (1:200, Chemicon/
Millipore), or a combination of rabbit polyclonal anti-ZO-1
antibody (1:400, Zymed Laboratories, Carlsbad, CA) and mouse
monoclonal anti-occludin antibody (1:500, Zymed) in PBS with
1% bovine serum albumin (BSA, Sigma) overnight at 4uC. The
cells were rinsed with PBS, then incubated with anti-rabbit or anti-
mouse secondary antibodies conjugated to Alexa-Fluor 488 and
Alexa Fluor 633 (Molecular Probes/Invitrogen) at 1:500 dilution
made in PBS with 1% BSA. Cells were then mounted with
ProLong Gold with DAPI (Invitrogen) and coverslips applied to
glass slides. Slides were analyzed for cytokeratin 18 with a Zeiss
Axiovert 200M inverted fluorescent microscope using 40x and
100x oil-immersion objectives. ZO-1 and occludin expression was
assessed with a Zeiss LSM510 confocal microscope equipped with
argon 488 nm and HeNe 633 nm laser light sources. Optical
sections were taken at 0.5 mm intervals. Orthogonal and z-stack
reconstructions were performed with NIH Image J 1.37a software.
Reverse transcriptase PCR of cytokeratin 18, cytokeratin
20, and uroplakin II
ULTI cells as well as YAMC, MSIE, and ImSt gastrointestinal
cells and NIH 3T3 fibroblasts were seeded into type I collagen-
Figure 2. The ULTI mouse urothelial cell line has an intact DNA
damage response under permissive conditions, but aberrant
cell cycle checkpoint and apoptosis activation which normal-
izes under non-permissive conditions. A) Western blot of whole
cell lysates from NIH 3T3 fibroblasts or ULTI cells under both permissive
and non-permissive conditions, pretreated with pifithrin-a or DMSO
vehicle, then exposed to etoposide or DMSO vehicle. B) Cell cycle
analysis by propidium iodide DNA labeling flow cytometry of ULTI cells
treated with etoposide (ETOP) or DMSO vehicle under both permissive
conditions with 10% FBS, and non-permissive conditions with 0.5% FBS.
C) Quantitation of cell cycle phase of ULTI cells treated with etoposide
(ETOP) or DMSO vehicle under both permissive conditions with 10%
FBS and non-permissive conditions with 0.5% FBS. Dark grey bars
indicate percent of cells in G0/G1, white bars indicate percent of cells in
S phase, and light grey bars indicate percent of cells in G2/M phase.
Error bars represent standard error of the mean.
doi:10.1371/journal.pone.0016595.g002
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sensitive to p53 inhibition. A) Cell cycle analysis by propidium iodide DNA labeling flow cytometry of ULTI cells pretreated with pifithrin-a (PFTa)
or DMSO vehicle, then treated with etoposide (ETOP) or DMSO vehicle under non-permissive conditions with 0.5% FBS. B) Quantitation of cell cycle
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c, and maintained at 37uC for four days. Cells were scraped into
ice-cold sterile PBS, pelleted, and total cellular RNA was extracted
from pelleted cells using TRI reagent (Sigma) according to the
manufacturer’s instructions and quantitated by spectrophotome-
try.
In experiments designed to mimic the hyperosmolal bladder
microenvironment, ULTI cells were gradually adapted to
hyperosmolality in culture by increasing the media osmolality by
50 mOsm/kg every 24 hours from a basal media osmolality (,300
mOsm/kg) to target osmolalities of 450 and 600 mOsm/kg. Cells
were seeded into plastic dishes with media lacking IFN-c and
containing 0.5% FBS and maintained at 37uC. Every 24 hours,
culture media was aspirated and replaced with fresh media
adjusted to the corresponding osmolality by the addition of sterile-
filtered 5M NaCl (Sigma) or 5M urea (Fluka). To remove
isocyanates, a degradation product of urea, 20 mL of 5M urea
stock solution was exchanged with 1 g of AG-501-X8 resin (Bio-
Rad) in the method published by Zhang et al [35] immediately
prior to use. Cells were scraped into PBS and total cellular RNA
extracted with TRI reagent as above.
To provide tissue RNA for comparison, total cellular RNA was
extracted with TRI reagent from homogenized stomach, intestine,
heart, and bladder tissue from euthanized wild-type mice.
Following treatment of 0.3–1 mg of extracted RNA with 2 Units
of RNAse-free DNAse I (New England Biolabs, Ipswich, MA) and
heat deactivation of the DNAse, cDNA was generated by reverse
transcription using oligo-dT20 primers and the SuperScript III
First-Strand Synthesis System (Invitrogen) according to the
manufacturer’s instructions. Aliquots of cDNA were then used to
detect cytokeratin 18, cytokeratin 20, uroplakin II, and G3PDH
by PCR with AccuPower PCR PreMix tubes (Bioneer, Alameda,
CA). Forward and reverse primer sets, PCR reaction annealing
temperature, and predicted product sizes are listed in Table 1. The
PCR program template for all reactions was as follows: 94uC65
minutes, followed by forty cycles of (94uC61 minute, annealing
temperature630 seconds, 72uC630 sec), and final extension of
72uC610 minutes. PCR products were separated by agarose gel
electrophoresis, stained with SYBRH Safe (Invitrogen) and imaged.
Results
ULTI cells regulate cell proliferation normally under non-
permissive conditions
Cells grown in permissive conditions for SV40 large T antigen
expression (33uC +IFN-c) continued to show robust proliferation
as measured by crystal violet assay despite a reduction in FBS
concentration from 10% through to 0.5% (Figure 1a). However,
cells grown in non-permissive conditions (37uC -IFN-c) had a
normal stepwise reduction in cell proliferation at each decreasing
concentration of FBS. The difference in absorbance between cells
cultured in permissive versus non-permissive conditions was
statistically significant (p,0.05) at 3%, 2%, 0.75%, and 0.5% FBS.
Aneuploidy was excluded in cells grown under both permissive
and non-permissive conditions by cell cycle analysis with flow
cytometry using propidium iodide DNA labeling (Figure 1b). Cells
cultured under non-permissive conditions with either 10% or
0.5% FBS demonstrated a reduction in the proportion of cells in
S-phase and an increase of cells in G0/G1 compared to cells
cultured at permissive conditions with the same FBS concentration
(Figure 1c), indicating proliferation may be manipulated by
inducing or suppressing SV40 large T antigen expression.
The DNA damage response of ULTI cells is unaffected by
conditional immortalization
The DNA damage response pathway was assessed by western
blot analysis in whole cell lysates from ULTI cells exposed to
etoposide under both permissive and non-permissive conditions, as
well as NIH 3T3 cells. This pathway was appropriately activated
following induction of DNA damage with etoposide in ULTI cells
cultured under both permissive and non-permissive conditions as
determined by both autophosphorylation of the ataxia telangecta-
sia mutated (ATM) kinase on serine 1981 and phosphorylation of
H2AX on serine 319 (cH2AX) by ATM (Figure 2a). This
activation was increased under permissive conditions when
compared to non-permissive conditions, which could be explained
by progression through the cell cycle despite the presence of
double strand DNA breaks.
SV40 large T antigen expression was substantially reduced in
cells grown under non-permissive conditions compared to cells in
permissive conditions (Figure 2a), confirming the conditional
transformation of this cell line. Treatment of cells with etoposide
also caused a substantial reduction in cellular levels of SV40 large
T antigen. The large T antigen is known to undergo targeted
proteasomal degradation as part of the DNA damage response
[36].
phase of ULTI cells pretreated with pifithrin-a (PFTa) or DMSO vehicle, then treated with etoposide (ETOP) or DMSO vehicle under non-permissive
conditions with 0.5% FBS. Dark grey bars indicate percent of cells in G0/G1, white bars indicate percent of cells in S phase, and light grey bars indicate
percent of cells in G2/M phase. Error bars represent standard error of the mean.
doi:10.1371/journal.pone.0016595.g003
Figure 4. The ULTI mouse urothelial cell line exhibits an
epithelial morphology. A) Phase contrast micrograph obtained with
20X objective of a monolayer of ULTI cells, showing a polygonal
morphology. B) Phase contrast micrograph obtained with 20X objective
of ULTI cells demonstrating the organization of these cells into densely
packed sheets. C) Phase contrast micrograph obtained with 20X
objective of a confluent monolayer of RT4 transitional cell carcinoma
cell line, also demonstrating a densely packed arrangement of smaller
cells. D) Scanning electron micrograph (500X) of ULTI cells, showing a
domed, polygonal morphology with smooth apical surface. Bar at the
bottom right of the panel represents 100 mm.
doi:10.1371/journal.pone.0016595.g004
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inhibited under permissive conditions through a
functional inactivation of p53
Levels of p53 were increased in cells grown under permissive
conditions compared to cells grown under non-permissive conditions
(Figure 2a), indicating sequestration and decreased degradation of p53
d u et oi t sb i n d i n gt oS V 4 0l a r g eTa n t i g e na tp e r m i s s i v ec o n d i t i o n s .
The phosphorylation of p53 on serine 15 increased with etoposide
exposure under both permissive and non-permissive conditions
(Figure 2a). However, levels of p21, an effector of cell cycle arrest
whose expression is induced by p53, were significantly increased in cells
grown under non-permissive conditions when compared to those
grown under permissive conditions, although p21 expression increased
followingexposuretoetoposideunderpermissiveconditions(Figure2a).
As measured by flow cytometry, G1/S-phase cell cycle
checkpoint activation was attenuated under permissive conditions
(Figure 2b, upper panels). Cells exposed to DNA damage induced
by etoposide under these conditions had similar proportions of
cells in S-phase comparing etoposide treatment (52.9%) to control
(47.7%, Figure 2c). In contrast, cells cultured under conditions
non-permissive for large T antigen expression and exposed to
etoposide displayed a prominent S-phase arrest (Figure 2b, lower
panels), with a significant increase in the population of S-phase
cells in response to damage (from 21.9% to 44.3%) indicating
activation of this cell cycle checkpoint (Figure 2c).
The checkpoint activation under non-permissive conditions was
sensitive to p53 inhibition. Pretreatment with pifithrin-a led to a
diminution of the S-phase arrest (Figure 3a, lower panels) and
reduction in the S-phase population of cells damaged with
etoposide (18.0%, Figure 3b) when compared to cells pretreated
with DMSO vehicle then damaged with etoposide (34.8%). The
reduction in S-phase arrest in cells cultured under non-permissive
conditions, pretreated with pifithrin-athen damaged with etopo-
side indicates that p53 is functionally active under non-permissive
conditions and mediates the S-phase arrest.
Irreversible DNA damage that accumulates to a critical
threshold triggers apoptosis, mediated in large part by p53 and
induction of its effectors, PUMA and Bax. Cells damaged with
etoposide under permissive growth conditions had a substantial
decrease in activation of the apoptotic pathway as determined by
cleavage of caspase 3, a key step at the convergence of the intrinsic
and extrinsic apoptosis pathways, and poly-ADP ribose polymer-
ase (PARP), a downstream substrate of caspase 3, when compared
to cells damaged under non-permissive conditions (Figure 2a). The
activation of the apoptotic pathway in cells damaged with
etoposide under non-permissive conditions was blunted by
pretreatment with pifithrin-a, indicating p53 is indeed a mediator
of DNA damage-induced apoptosis under such conditions.
NIH 3T3 fibroblasts, used as a control murine cell line with wild-
type p53 and lacking SV40 Large T antigen expression, demonstrated
a normal activation of ATM, cH2AX, increase in p21 abundance,
cleavage of caspase 3, and PARP following exposure to etoposide
(Figure 2a). Cellular abundance of p53 was much less in the NIH 3T3
cells than in the ULTI cell line, but both total p53 levels and
phosphorylation of p53 on serine 15 were found to be appropriately
increased following damage with etoposide (data not shown).
ULTI cells have an epithelial morphology consistent with
bladder urothelium, and express epithelial protein
markers
Phase contrast images of the ULTI cell line revealed a
monolayer of domed, polygonal cells with epithelial morphology
Figure 5. The ULTI cell line expresses epithelial markers of differentiation. A) Cytokeratin 18 immunofluorescence of ULTI cells, obtained
with 40X objective. Filamentous staining is noted characteristic of the cytokeratins. B) Cytokeratin 18 immunofluorescence of RT4 transitional cell
carcinoma cells, obtained with 40X objective. Similar staining to ULTI cells is noted. Withholding primary antibody to assess nonspecific binding of
the secondary antibody found no such staining. C) Confocal immunofluorescence of ULTI cells. Circumferential linear staining is noted with occludin
(green, left panel) and ZO-1 (red, middle panel), which colocalizes upon merge of the images (yellow, right panel). D) Orthogonal reconstruction of
axial images demonstrating colocalization of occludin and ZO-1.
doi:10.1371/journal.pone.0016595.g005
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suggestive of mature tight junctions and focal adhesions [37]. This
cluster arrangement is characteristic of other cell lines of urothelial
origin such as the transitional cell carcinoma line RT4 (Figure 4c),
which is by comparison smaller than primary urothelial cells [24].
Scanning electron microscopy of ULTI cells also demonstrated a
densely packed monolayer of domed polygonal cells (Figure 4d),
although the cell surface appeared smooth, lacking ridges
consistent with the AUM in fully differentiated urothelial or
‘‘umbrella’’ cells.
ULTI mouse urothelial cells expressed cytokeratin 18 in a
cytoplasmic distribution characteristic of the intermediate filament
compartment (Figure 5a). A similar staining pattern was noted in
the RT4 transitional carcinoma cell line (Figure 5b), supporting
the epithelial nature of the derived mouse cell line. To further
define the epithelial nature of these cells, expression of the tight
junction proteins ZO-1 and occludin were characterized by
confocal immunofluorescent microscopy. The ULTI cell line
exhibited linear staining for both ZO-1 and occludin in a
circumferential pattern (Figure 5c), which colocalized both in the
axial plane and upon orthogonal reconstruction of the confocal
images (Figure 5d). RT4 cells also demonstrated a similar
circumferential staining with ZO-1 and occludin, whereas the
3T3 fibroblast cell line demonstrated discrete staining only at focal
cell-cell junctions (data not shown).
Differentiation state of ULTI cell line
To further define the differentiation state of the ULTI cell line,
gene expression analysis for cytokeratins and uroplakin was
undertaken using RT-PCR. These studies compared expression
from the ULTI cell line as well as other conditionally immortalized
epithelial cell lines (YAMC, MSIE, ImSt) and from various mouse
tissues. Both the ULTI cell line and the conditionally immortalized
gastrointestinal cell lines expressed cytokeratin 18, but did not
express cytokeratin 20 (Figure 6a) under standard non-immortal-
ized culture conditions. Mouse stomach, intestine and bladder
tissue all demonstrated expression of both CK18 and CK20
(Figure 6b). Uroplakin II expression was limited to mouse bladder
tissue and was not expressed by the ULTI cell line under standard
conditions (Figure 6b). Following gradual adaptation of the ULTI
cells to 450mOsm/kg and 600mOsm/kg with sodium chloride,
but not urea, expression of uroplakin II was detected (Figure 6c).
Cytokeratin 20 expression was also following adaptation to
450mOsm/kg and 600mOsm/kg with sodium chloride as well
as urea (Figure 6c). Amplification of G3PDH confirmed equal
loading of RNA and generation of cDNA (Figures 6a, 6b, and 6c).
Discussion
In order to develop meaningful strategies aimed at the
prevention and treatment of bladder cancer, and especially cancer
of the augmented bladder, a greater understanding of the role of
the DNA damage response, DNA repair, activation of cell cycle
checkpoints and apoptosis, and the influence of the bladder
microenvironment on these processes in both native bladder and
gastrointestinal tissues is critical. Population based genetic studies
have indicated a role for DNA repair proteins like ERCC1 [38] as
well as the MYC, TP63, and PSCA loci (reviewed in [39]) in the
pathogenesis of bladder cancer but unfortunately, there are no
suitable in vitro models of urothelium that have proper regulatory
control of cell cycle checkpoints and apoptosis as well as an intact
DNA damage response.
To address this limitation, we have developed a conditionally
immortalized mouse urothelial cell line that exhibits an epithelial
morphology (Figure 4), formation of tight junctions (Figure 5), and
expressionofurothelialmarkerssuchascytokeratin18.(Figures5and
6). Under the standard isoosmolal culture conditions used for the cell
proliferation, DNA damage response, and cell cycle analysis
experiments, ULTI cells did not terminally differentiate as they
lacked expression of cytokeratin 20 [40] or uroplakin II [11]
Figure 6. ULTI cells express cytokeratin 20 and uroplakin II in
addition to cytokeratin 18 under hyperosmolal conditions.
A) RT-PCR of cytokeratin 18, cytokeratin 20, and G3PDH using RNA
isolated from cell lines. B) RT-PCR of cytokeratin 18, cytokeratin 20,
uroplakin II, and G3PDH from RNA isolated from mouse tissues and ULTI
cell line. C) RT-PCR of cytokeratin 18, cytokeratin 20, uroplakin II, and
G3PDH from RNA isolated from ULTI cell line under basal and
hyperosmolal conditions and NIH 3T3 cells. The panel displaying the
uroplakin II PCR products is composed of two images from two
separate areas of the same gel image.
doi:10.1371/journal.pone.0016595.g006
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under standard culture conditions has been observed with other
conditionally immortalized cell lines such as the gastrointestinal
YAMC, MSIE, and ImSt cell lines [41] and even successive passages
of primary urothelial cells [17,42]. As expression of both cytokeratin
20 and uroplakin II were detected following adaptation to a
hyperosmolal milieu (Figure 6c), chronic osmotic stress may serve
as a differentiation stimulus in these cells towards an ‘‘umbrella cell’’
phenotype, suggesting that induction of cytokeratin 20 and uroplakin
expression in this cell line may be linked to activation of elements of
the osmotic stress response by proteins such as TonEBP [43].
This urothelial cell line can be subcultured more than 50
passages under permissive cell culture, but has a stable phenotype
under non-permissive conditions. The conditional transformation
of ULTI cells was confirmed as cells under permissive conditions
displayed robust proliferation over a wide range of FBS
concentrations (Figures 1a and 1b), indicating that the induced
expression of SV40 large T antigen is the primary determinant of
cell proliferation under these conditions. Cells grown under non-
permissive conditions showed an expected stepwise decrease in cell
proliferation with decreasing FBS concentration, indicating
normal cell cycle control and regulation of proliferation in
response to the reduction of growth factors.
ULTI cells demonstrated an appropriate activation of the DNA
damage response pathway mediated by ATM and its downstream
targets such as cH2AX in cells exposed to etoposide under both
permissive and non-permissive conditions. However, only ULTI
cells exposed to etoposide under non-permissive conditions
activated a G1/S-phase cell cycle checkpoint, and activated
mediators of apoptosis such as caspase-3 and PARP (Figures 2a
and 2b), whereas cells under permissive conditions failed to
respond in this normal fashion. Levels of p53 were higher under
permissive conditions corresponding to increased expression and
stability of the SV40 large T antigen and subsequent binding to,
and sequestration of, p53 [22]. However, levels of p21 were
dramatically increased in the cells under non-permissive condi-
tions despite decreased abundance of p53. This finding is expected
because intracellular levels of p21 are affected by other regulators
of the cell cycle, such as p16
INK4a [44], and are involved in cellular
quiescence [45]. ULTI cells under non-permissive conditions with
very low (0.5%) FBS concentration had decreased proliferation
(Figure 1a) and an increased population of G0/G1 cells (Figure 1b),
supporting the likelihood that p21 expression was induced in such
a p53-independent manner.
Phosphorylation of p53 on serine 15 following etoposide
treatment occurred under both permissive and non-permissive
conditions (Figure 2a). Although the overall abundance of p53 was
greater under permissive conditions, the degree of change between
DMSO and etoposide treatment was much greater under non-
permissive conditions indicating a more sensitive detection of
DNA damage under non-permissive conditions mediated by p53.
Selective inhibition of p53 activity with pifithrin led to a decreased
level of cleaved caspase 3 and cleaved PARP under non-permissive
conditions following etoposide treatment (Figure 2a), as well as a
blunted activation of the G1/S cell cycle checkpoint (Figures 3a
and 3b). This confirms that, under such conditions, p53 plays a
critical role in the activation of cell cycle checkpoints and apoptosis
due to DNA damage induced by etoposide. This finding supports
the notion that p53 is no longer sequestered by the SV40 large T
antigen and would therefore be able to induce expression of its
apoptotic effectors such as Bax and PUMA.
In conclusion, the ULTI mouse urothelial cell line is both well-
differentiated and conditionally immortalized due to the ability to
modulate cellular levels of the SV40 large T antigen following
adjustment of the cell culture milieu. Although the DNA damage
response mediated by ATM is intact in these cells under both
permissive and non-permissive conditions, activation of cell cycle
checkpoints and apoptosis may be inhibited by the induced
expression of the SV40 large T antigen under permissive
conditions promoting cell proliferation despite the presence of
DNA damage. These pathways are restored when cells are grown
under non-permissive conditions. This reversible immortalization
is unique to this urothelial cell line, and makes this cell line the
optimal model for the characterization of cell cycle checkpoint
activation, apoptosis, and the DNA damage response in
urothelium. This cell line will be critical in experiments aimed at
providing insight into the effect of bladder microenvironment on
the DNA damage response and into the pathomechanisms leading
to carcinogenesis of native and augmented bladders.
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